Skip to main content
. Author manuscript; available in PMC: 2009 Jul 28.
Published in final edited form as: J Invest Dermatol. 2008 Jun 26;129(1):167–174. doi: 10.1038/jid.2008.181

Figure 2. Intradermal injection of CPAF does not induce thermal hyperalgesia.

Figure 2

Columns represent the mean ± SEM (n = 4 mice per group) paw withdrawal latency in seconds 4 hours (gray columns) and 16 hours (black columns) after intradermal injection of BSA or CFAP (specific PAF-R agonist, 50 µl volume) into the hind paw. There were no statistically significant differences between groups using a repeated-measures ANOVA.